Hypofractionation redux?

被引:19
作者
Goffman, TE [1 ]
Glatstein, E
机构
[1] Eastern Virginia Med Sch, Dept Radiat Oncol, Norfolk, VA 23501 USA
[2] Univ Penn, Med Ctr, Dept Radiat Oncol, Philadelphia, PA 19104 USA
关键词
D O I
10.1200/JCO.2004.07.174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:589 / 591
页数:3
相关论文
共 12 条
[1]   Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. [J].
Bartelink, H ;
Horiot, J ;
Poortmans, P ;
Struikmans, H ;
Van den Bogaert, W ;
Barillot, I ;
Fourquet, A ;
Borger, J ;
Jager, J ;
Hoogenraad, W ;
Collette, L ;
Pierart, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) :1378-1387
[2]  
COX JD, 1985, CANCER-AM CANCER SOC, V55, P2105, DOI 10.1002/1097-0142(19850501)55:9+<2105::AID-CNCR2820551412>3.0.CO
[3]  
2-T
[4]  
Ellis F, 1942, BRIT J RADIOL, V15, P348
[5]   HYPOFRACTIONATION - LESSONS FROM COMPLICATIONS [J].
FLETCHER, GH .
RADIOTHERAPY AND ONCOLOGY, 1991, 20 (01) :10-15
[6]   Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients [J].
Johansson, S ;
Svensson, H ;
Denekamp, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03) :745-750
[7]   Left sided vocal cord paralysis:: a newly recognized late complication of mediastinal irradiation [J].
Johansson, S ;
Löfroth, PO ;
Denekamp, J .
RADIOTHERAPY AND ONCOLOGY, 2001, 58 (03) :287-294
[8]   IMPACT OF ADJUVANT CHEMOTHERAPY ON COSMESIS AND COMPLICATIONS IN STAGE-I AND STAGE-II CARCINOMA OF THE BREAST TREATED BY BIOPSY AND RADIATION-THERAPY [J].
RAY, GR ;
FISH, VJ ;
MARMOR, JB ;
ROGOWAY, W ;
KUSHLAN, P ;
ARNOLD, C ;
LEE, RH ;
MARZONI, F .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (06) :837-841
[9]   Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France [J].
Romestaing, P ;
Lehingue, Y ;
Carrie, C ;
Coquard, R ;
Montbarbon, X ;
Ardiet, JM ;
Mamelle, N ;
Gerard, JP .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :963-968
[10]  
Sartor CI, 2002, J NATL CANCER I, V94, P1114